文献速递肾移植

肾移植受者的心血管钙化

Cardiovascular calcifications in kidney transplant recipients.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

肾移植受者中血管和瓣膜钙化高度普遍,与心血管事件风险增加相关,而心血管事件是这些患者长期死亡的主要原因。尽管尿毒症相关代谢紊乱部分或完全缓解,肾移植受者仍暴露于多种促钙化刺激,促进原有血管钙化进展或新发钙化。本文综述肾移植中心血管钙化发病机制的已知和推测介质、临床与影像特征,以及预防策略和新型治疗候选药物。

要点

  • 肾移植受者血管和瓣膜钙化高度普遍,与心血管事件风险增加相关。
  • 传统危险因素、骨矿物质紊乱、炎症、免疫抑制剂和钙化抑制剂缺乏均可能起作用。
  • 亟需纠正或最小化促钙化因素的策略,并探索新型治疗候选药物。

核心结论

  • 肾移植受者心血管钙化高度普遍且与心血管事件风险增加相关,是长期死亡主因。

研究设计与样本

  • 综述,概述肾移植中心血管钙化发病机制的已知和推测介质及临床影像特征。

主要发现

  • 尽管尿毒症相关代谢紊乱部分或完全缓解,肾移植受者仍暴露于多种促钙化刺激。
  • 传统危险因素、骨矿物质紊乱、炎症、免疫抑制剂和钙化抑制剂缺乏均可能参与。

临床怎么用

  • 临床需关注肾移植受者心血管钙化的评估与预防,以降低心血管事件风险。

局限性

  • 原文未报告具体研究设计细节及样本量等局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vascular and valvular calcifications are highly prevalent in kidney transplant recipients (KTRs) and are associated with an increased risk of cardiovascular events, which represent the leading cause of long-term mortality in these patients. However, cardiovascular calcification has been traditionally considered as a condition mostly associated with advanced chronic kidney disease stages and dialysis, and comparatively fewer studies have assessed its impact after kidney transplantation. Despite partial or complete resolution of uraemia-associated metabolic derangements, KTRs are still exposed to several pro-calcifying stimuli that favour the progression of pre-existing vascular calcifications or their de novo development. Traditional risk factors, bone mineral disorders, inflammation, immunosuppressive drugs and deficiency of calcification inhibitors may all play a role, and strategies to correct or minimize their effects are urgently needed. The aim of this work is to provide an overview of established and putative mediators involved in the pathogenesis of cardiovascular calcification in kidney transplantation, and to describe the clinical and radiological features of these forms. We also discuss current evidence on preventive strategies to delay the progression of cardiovascular calcifications in KTRs, as well as novel therapeutic candidates to potentially prevent their long-term deleterious effects.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Podestà MA, Cucchiari D, Ciceri P, et al. Cardiovascular calcifications in kidney transplant recipients. Nephrol Dial Transplant. 2022. PMID: 33620476. doi:10.1093/ndt/gfab053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。